Phase 3 Readout

ANNX: Phase 3 Topline: A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of t

Name: Phase 3 Topline: A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of t
Start: 2027-07-31
End: 2027-07-31

July 31, 2027. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date: July 31, 2027
Company: Annexon, Inc. (ANNX)

BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Phase 3 Readout~month

Phase 3 Topline: A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of t

July 31, 2027

ANNX overview →

Company: Annexon, Inc. (ANNX)
Indication: Geographic Atrophy